Proteomics International Laboratories Ltd. (AU:PIQ) has released an update.
Proteomics International Laboratories Ltd has partnered with Eurobio Scientific as the exclusive distributor of PromarkerD, a diagnostic test for predicting diabetic kidney disease, in the French market. With diabetes affecting 3.9 million adults in France and high rates of end-stage renal disease, the PromarkerD test offers significant potential for early detection and prevention of disease progression. The collaboration leverages Eurobio Scientific’s robust distribution network and expertise in specialty diagnostics to meet the needs of this critical healthcare segment.
For further insights into AU:PIQ stock, check out TipRanks’ Stock Analysis page.
